The University of Southampton
University of Southampton Institutional Repository

Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics

Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics
Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics
Objective: To determine if mortality, multi-organ failure and haemodynamic instability in fulminant hepatic failure are related to levels of circulating acute phase cytokines. Design: A prospective study of patients admitted with fulminant hepatic failure. Setting: A UK national referral centre for the management of acute liver failure based in the specialist liver intensive care unit of a large teaching hospital. Patients: Patients with acute liver failure were studied in two cohorts (n = 57 and n = 63). Interventions: Blood sampling, detailed haemodynamic studies. Measurements: Plasma interleukin 6 (IL-6), interleukin 8 (IL-8), tumour necrosis factor alpha (TNF), endotoxin, p55 and p75 soluble tumour necrosis factor receptors. Clinical and haemodynamic parameters. Main results: In the initial cohort (n = 57) circulating levels of interleukin 6 and 8 but no other parameters were associated with mortality. IL-6 and to a lesser extent IL-8 were significantly associated with haemodynamic instability as assessed by systolic hypotension. In a further cohort comprising 63 patients who underwent detailed haemodyamic assessment IL-6 levels were significantly associated with acidosis, systemic vascular resistance, oxygen consumption and low mean arterial pressure. Conclusions: Mortality in acute liver failure is associated with high levels of the circulating acute phase cytokines IL-6 and IL-8, independently of endotoxaemia. Levels of IL-6 in particularare closely associated with the severity of haemodynamic instability, similar to the pattern seen in septic shock. The underlying mechanism of circulatory derrangement in acute liver failure remains unknown, but patterns of proinflammatory cytokine mediator are very similar to those found in sepsis, and are not related to endotoxaemia.
127-134
Sheron, N.
cbf852e3-cfaa-43b2-ab99-a954d96069f1
Keane, H.
f3ce1285-f585-4726-8bb5-e49bca98a330
Goka, J.
157fa443-649d-4054-95f9-f754d9048074
Alexander, G.
a6e5b2a7-e06b-4149-8ad2-488c86cc5b2c
Williams, R.
49181762-00c1-4043-9247-a9bcddbd04f7
Wendon, J.
737c11c5-ee68-4a24-8b15-ca9129e09a08
Sheron, N.
cbf852e3-cfaa-43b2-ab99-a954d96069f1
Keane, H.
f3ce1285-f585-4726-8bb5-e49bca98a330
Goka, J.
157fa443-649d-4054-95f9-f754d9048074
Alexander, G.
a6e5b2a7-e06b-4149-8ad2-488c86cc5b2c
Williams, R.
49181762-00c1-4043-9247-a9bcddbd04f7
Wendon, J.
737c11c5-ee68-4a24-8b15-ca9129e09a08

Sheron, N., Keane, H., Goka, J., Alexander, G., Williams, R. and Wendon, J. (2001) Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics. Clinical Intensive Care, 12 (3), 127-134. (doi:10.1080/714028754).

Record type: Article

Abstract

Objective: To determine if mortality, multi-organ failure and haemodynamic instability in fulminant hepatic failure are related to levels of circulating acute phase cytokines. Design: A prospective study of patients admitted with fulminant hepatic failure. Setting: A UK national referral centre for the management of acute liver failure based in the specialist liver intensive care unit of a large teaching hospital. Patients: Patients with acute liver failure were studied in two cohorts (n = 57 and n = 63). Interventions: Blood sampling, detailed haemodynamic studies. Measurements: Plasma interleukin 6 (IL-6), interleukin 8 (IL-8), tumour necrosis factor alpha (TNF), endotoxin, p55 and p75 soluble tumour necrosis factor receptors. Clinical and haemodynamic parameters. Main results: In the initial cohort (n = 57) circulating levels of interleukin 6 and 8 but no other parameters were associated with mortality. IL-6 and to a lesser extent IL-8 were significantly associated with haemodynamic instability as assessed by systolic hypotension. In a further cohort comprising 63 patients who underwent detailed haemodyamic assessment IL-6 levels were significantly associated with acidosis, systemic vascular resistance, oxygen consumption and low mean arterial pressure. Conclusions: Mortality in acute liver failure is associated with high levels of the circulating acute phase cytokines IL-6 and IL-8, independently of endotoxaemia. Levels of IL-6 in particularare closely associated with the severity of haemodynamic instability, similar to the pattern seen in septic shock. The underlying mechanism of circulatory derrangement in acute liver failure remains unknown, but patterns of proinflammatory cytokine mediator are very similar to those found in sepsis, and are not related to endotoxaemia.

This record has no associated files available for download.

More information

Published date: 2001

Identifiers

Local EPrints ID: 72803
URI: http://eprints.soton.ac.uk/id/eprint/72803
PURE UUID: 52f7f8fc-c9d5-439c-9a07-85d7da4086d6
ORCID for N. Sheron: ORCID iD orcid.org/0000-0001-5232-8292

Catalogue record

Date deposited: 23 Feb 2010
Last modified: 13 Mar 2024 21:40

Export record

Altmetrics

Contributors

Author: N. Sheron ORCID iD
Author: H. Keane
Author: J. Goka
Author: G. Alexander
Author: R. Williams
Author: J. Wendon

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×